Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Francesco Benvenuti, Mariele Gatto, Maddalena Larosa, Luca Iaccarino, Leonardo Punzi & Andrea Doria. (2015) Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review. Expert Opinion on Drug Safety 14:9, pages 1373-1385.
Read now
Read now
Articles from other publishers (21)
Y Hadi, T Or, G Moady & S Atar. (2022) Psoriasis and coronary heart disease—not as severe as predicted. QJM: An International Journal of Medicine 115:6, pages 388-392.
Crossref
Crossref
Apinya Lertratanakul, Julia Sun, Peggy W Wu, Jungwha Lee, Alan Dyer, William Pearce, David McPherson, Kim Sutton-Tyrrell, Trina Thompson, Emma Barinas-Mitchell & Rosalind Ramsey-Goldman. (2021) Risk factors for changes in carotid intima media thickness and plaque over 5 years in women with systemic lupus erythematosus. Lupus Science & Medicine 8:1, pages e000548.
Crossref
Crossref
Allison B. Reiss, Benna Jacob, Saba Ahmed, Steven E. Carsons & Joshua DeLeon. (2021) Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention. Inflammation 44:5, pages 1663-1682.
Crossref
Crossref
Stephanie Saeli, Tanmayee Bichile, Payal Thakkar & Susan Manzi. 2021. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
415
426
.
Daniella Muallem Schwartz, Aarohan M. Burma, Moses M. Kitakule, Yiming Luo & Nehal N. Mehta. (2020) T Cells in Autoimmunity-Associated Cardiovascular Diseases. Frontiers in Immunology 11.
Crossref
Crossref
Myrto Kostopoulou, Dionysis Nikolopoulos, Ioannis Parodis & George Bertsias. (2020) Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention. Current Vascular Pharmacology 18:6, pages 549-565.
Crossref
Crossref
Iryna Voloshyna, Isaac Teboul, Lora J. Kasselman, Michael Salama, Steven E. Carsons, Joshua DeLeon, Joseph Mattana, Nobuyuki Miyawaki & Allison B. Reiss. (2019) Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A. Inflammation Research 68:9, pages 787-799.
Crossref
Crossref
Pauline Henrot, Jennifer Foret, Thomas Barnetche, Estibaliz Lazaro, Pierre Duffau, Julien Seneschal, Thierry Schaeverbeke, Marie-Elise Truchetet & Christophe Richez. (2019) Évaluation de l’athérosclérose infraclinique dans le lupus érythémateux systémique : revue de la littérature et méta-analyse. Revue du Rhumatisme 86:3, pages 232-240.
Crossref
Crossref
Toshihiko Yanase. (2018) 3) Cushing's Syndrome and Subclinical Cushing's Syndrome3）クッシング・サブクリニカルクッシング症候群. Nihon Naika Gakkai Zasshi 107:9, pages 1766-1771.
Crossref
Crossref
Naina Mohamed Pakkir Maideen, Gobinath Manavalan & Kumar Balasubramanian. (2018) Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter. Therapeutic Advances in Endocrinology and Metabolism 9:8, pages 259-268.
Crossref
Crossref
Pauline Henrot, Jennifer Foret, Thomas Barnetche, Estibaliz Lazaro, Pierre Duffau, Julien Seneschal, Thierry Schaeverbeke, Marie-Elise Truchetet & Christophe Richez. (2018) Assessment of subclinical atherosclerosis in systemic lupus erythematosus: A systematic review and meta-analysis. Joint Bone Spine 85:2, pages 155-163.
Crossref
Crossref
Vítor Teixeira & Lai-Shan Tam. (2018) Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis. Frontiers in Medicine 4.
Crossref
Crossref
Nalinee Pattrakornkul, Patamakom Pruangprasert, Prakul Chanthong, Ratana Chawanasuntorapoj & Anirut Pattaragarn. (2017) Subclinical atherosclerosis in young Thai adults with juvenile-onset systemic lupus erythematosus. Asian Biomedicine 10:2, pages 139-146.
Crossref
Crossref
C. Nardin, M. Rattazzi & P. Pauletto. 2017. The Heart in Systemic Autoimmune Diseases. The Heart in Systemic Autoimmune Diseases
89
122
.
Abdullah Icli, Erkan Cure, Medine Cumhur Cure, Ali Ugur Uslu, Sevket Balta, Dimitri P. Mikhailidis, Cengiz Ozturk, Sevket Arslan, Davut Sakız, Muhammed Sahin & Adem Kucuk. (2016) Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus. Angiology 67:8, pages 749-755.
Crossref
Crossref
Fotini Gravani, Ioanna Papadaki, Eleni Antypa, Andrianos Nezos, Kyriaki Masselou, Dimitrios Ioakeimidis, Michael Koutsilieris, Haralampos M Moutsopoulos & Clio P Mavragani. (2015) Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations. Arthritis Research & Therapy 17:1.
Crossref
Crossref
S. Fadda, H. Nassar, S.M. Gamal & H. Al-azizi. (2014) Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indicesSubklinische Atherosklerose bei Patienten mit systemischem Lupus erythematodes und deren Zusammenhang zwischen Krankheitsaktivität und Schweregradindizes. Zeitschrift für Rheumatologie 74:6, pages 529-532.
Crossref
Crossref
Hala A. Raafat, Samar M. Fawzy & Hussein S. El Fishawy. (2015) Intima-media thickness in secondary anti-phospholipid syndrome patients: Impact of disease activity. The Egyptian Rheumatologist 37:2, pages 55-60.
Crossref
Crossref
Bartłomiej Kisiel, Robert Kruszewski, Aleksandra Juszkiewicz, Anna Raczkiewicz, Artur Bachta, Małgorzata Tłustochowicz, Jadwiga Staniszewska-Varga, Krzysztof Kłos, Krzysztof Duda, Romana Bogusławska-Walecka, Rafał Płoski & Witold Tłustochowicz. (2015) Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis. Journal of Immunology Research 2015, pages 1-8.
Crossref
Crossref
L Eder, DD Gladman, D Ibañez & MB Urowitz. (2014) The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients. Lupus 23:11, pages 1142-1148.
Crossref
Crossref
Peter Seizer, Meinrad Gawaz & Andreas E. May. (2014) Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases. Cardiovascular Research 102:1, pages 17-23.
Crossref
Crossref